BOTENSILIMAB
UNII 1Z5YC3ME5N

Substance Identification & Data

This profile provides standardized clinical and technical data for Botensilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1Z5YC3ME5N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2408310-37-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1Z5YC3ME5N

CAS Registry Number

2408310-37-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BOTENSILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C158557

National Cancer Institute reference terminology for clinical and research data.

INN ID

11659

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-157

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Botensilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BOTENSILIMAB

Common Names & Synonyms

BOTENSILIMAB [INN]

BOTENSILIMAB [USAN]

BOTENSILIMAB [WHO-DD]

IMMUNOGLOBULIN G1 (240-ASPARTIC ACID,331-LEUCINE,333-GLUTAMIC ACID,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN MONOCLONAL AGEN1181 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AGEN1181 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE ASSOCIATED PROTEIN 4, CD152)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-447) (VH (HOMO SAPIENS IGHV3-21*01 (99.0%) -(IGHD) - IGHJ3*02 (92.9%) M123>L (113)) CDR-IMGT (8.8.11) (26-33.51-58.97-107) (1-118) -HOMO SAPIENS IGHG1*03 G1M3, NG1M1, G1V8 CH2 D3, L115, E117 (CH1 R120 (215) (119-216), HINGE 1-15 (217-231), CH2 S3>D (240), A115>L (331), I117>E (333) (232- 341), CH3 E12 (357), M14 (359) (342-446), CHS K>DEL (447)) (119-447)), (221-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV3-20*01 (94.8%) -IGKJ1*01 (100%)) CDR-IMGT (6.3.9) (27-32.50-52.89-97) (1'- 107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (227-227'':230- 230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

Technical Codes

AGEN1181

AGEN-1181

External Clinical & Regulatory Resources

Previous UNII1Z5T1704U4

Next UNII1Z66WP2W94